US Stock MarketDetailed Quotes

GLMD Galmed Pharmaceuticals

Watchlist
  • 0.3874
  • +0.0023+0.60%
Close May 3 16:00 ET
  • 0.3989
  • +0.0115+2.97%
Post 16:06 ET
2.33MMarket Cap-154P/E (TTM)

Galmed Pharmaceuticals Key Stats

Galmed Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.98

+34.67%

No Data

Galmed Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
May 2, 20222021/Q40.000 / 0.000--
Nov 8, 20212021/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
May 2, 20222021/Q40.000 / 0.000--
Nov 8, 20212021/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Galmed Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg